Work

Alectinib for the treatment of ALK-positive stage IV non-small cell lung cancer

Year: 2015

Type: article

Source: Drugs of today

DOI: 10.1358/dot.2015.51.3.2294597

Authors: Wong, K.M., Noonan, S., O'Bryant, C., Jimeno, A.

Institutions: University of Colorado Anschutz, University of Colorado Denver

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2077098004

FWCI: 0.794

Cites:

Cited by: 8

Related to: 10